Repeatable Battery for the Assessment of Neuropsychological Status UpdateRBANS Update
- A brief individually administered battery to measure cognitive decline or improvement across five domains in ages 12 to 89 years 11 months
- Publication date:
- Completion time:
- 30 minutes
- Individual; Q-interactive administration and scoring; Q-global scoring and reporting; or manual scoring
- Age range:
- 12 to 89 years 11 months
- Qualification level:
The RBANS Update provides a brief, individually administered battery to measure cognitive decline or improvement across 5 domains:
This instrument is used by clinicians and neuropsychologists to help:
Features & Benefits
RBANS Update provides significant improvements, including:
Ideal for measuring change over time, RBANS Update offers four parallel forms. Form A offers a single set of norms based on age, gender, race, education, and geographic region with equating studies and adjustments for Forms B-D.
RBANS Update can also be used in a variety of ways including:
Although RBANS Update was originally developed with a primary focuson assessment of dementia, special group studies are available for Alzheimer’s Disease, Vascular Dementia, HIV Dementia, Huntington’s Disease, Parkinson’s Disease, Depression, Schizophrenia, and Closed Head Injury. With the additional collection of adolescent data, RBANS Update also has utility as a screener for neurocognitive status in younger patients as well. Finally, RBANS UPDATE has been used in a number of Clinical Trials and is available in over 20 languages.